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growth remains uncertain. If EGF is important in maintaining normal gut growth, the EGF receptor (EGF-R) should be present on the apical (luminal) surface in addition to the basolateral surface. Aims/Subjects/Methods-This study examined the distribution of the EGF-R in the epithelium throughout the human gastrointestinal tract using immunohistochemistry, electron microscopy, and western blotting of brush border preparations. Results-Immunostaining of the oesophagus showed circumferential EGF-R positivity in the cells of the basal portions of the stratified squamous epithelium but surface cells were EGF-R negative. In the normal stomach, small intestine, and colon, immunostaining localised the receptor to the basolateral surface with the apical membranes being consistently negative. EGF-R positivity within the small intestine appeared to be almost entirely restricted to the proliferative (crypt) region. Western blotting demonstrated a 170 kDa protein in whole tissue homogenates but not in the brush border vesicle preparations. Conclusions-As the EGF-R is located only on the basolateral surfaces in the normal adult gastrointestinal tract, the major role of luminal EGF is probably to stimulate repair rather than to maintain normal gut growth. (Gut 1996 Immunohistochemistry for EGF-R Mouse antihuman EGF-R monoclonal antibody was raised using purified human EGF-R, derived from A-431 cells, as the antigen (Triton Diagnostics, Alameda, CA, USA). Freshly cut sections were dewaxed and incubated in 100% alcohol. Endogenous peroxidase activity was blocked using a 10 minute incubation period in methanol containing 0.02% hydrogen peroxide (vol/vol). Sections were washed in phosphate buffered saline (PBS) and masked antigenic sites revealed by incubating in PBS solution containing 0.04% Nagarase (Cat no P-8038, Sigma UK) for 30 minutes. Sections were incubated in primary mouse antihuman EGF-R monoclonal antibody at a final dilution of 1:25 for 35 minutes, washed in PBS, and incubated in biotinylated rabbit antimouse antibody (Dako E354) at a final dilution of 1:500 to which 1:25 normal human serum had been added. Sections were again washed in PBS followed by incubation in streptavidin-peroxidase at 1:500 for 30 minutes. A brown reaction product was obtained using a peroxidase substrate (diaminobenzidine, PBS, in addition to 0.3% hydrogen peroxide). As a negative control, the primary antibody was omitted from the procedure. In addition, the specificity of the staining was confirmed by taking parallel sections and incubating in the presence of excess recombinant EGF-R.
Rabbit antihuman EGF-R polyclonal antibody 12E was produced by Gullick and coworkers using a short synthetic peptide sequence corresponding to residues 1164-1176 of the intracytoplasmic region of the EGF-R as the antigen.4 Sections were prepared as described above and incubated with the primary antibody at a final concentration of 1/40. The second antibody reaction consisted of incubating sections in biotinylated swine-antirabbit antibody at a final concentration of 1:500 to which 1:25 normal human serum had been added. As a negative control, the primary antibody was omitted from the procedure. In addition, the specificity of the staining was confirmed by taking parallel sections and incubating in the presence of excess recombinant EGF-R. and 1% normal goat serum) for eight hours at 4°C. Sections were washed three times over a 15 minute period with PBS containing 0.5% BSA, 0.5% ovalbumin, and 1% normal goat serum followed by incubation with immunogold conjugates (1:100 goat antirabbit IgG, 5 nm gold) for two hours. After rinsing in PBS (3Xfive minutes) and distilled water (3Xfive minutes), the sections were silver enhanced for four minutes at room temperature using an Intense M Silver Enhancement Kit (Amersham, UK) before contrasting with uranyl acetate and lead citrate. Sections were then examined using a Zeiss 10 C electron microscope. As a negative control, the primary antibody was omitted from the procedure.
Western blotting
Background to method-to determine if the apical membranes contained EGF-R, purified brush border vesicles were prepared and probed for the presence of EGF-R protein using western blotting. The quality of the brush border preparations was determined by following changes in the specific activity of alkaline phosphatase activity, whose expression is restricted to the apical membranes.5 Two rabbit polyclonal antibodies were used for these studies; 12E, which had also been used for the immunohistochemical localisation studies described above and a further affinity purified rabbit-antihuman EGF-R raised against a synthetic peptide corresponding to residues 1005 to 1016 of the human EGF receptor protein (EGFR-1005, Santa Cruz Biotechnology, Santa Cruz, CA).
Preparation of brush border vesicles-brush border preparations were made from duodenal and ileal tissue using the protocol described by Simpson, 6 Figure 1 : Immunohistochemical localisation of the EGF-R using rabbit antihuman polyclonal antibody 12E. EGF-R positivity was visualised using DAB, giving a brown reaction product. In the oesophagus, weak EGF-R positivity is seen circumferentially in cells of the basal region of the stratified squamous epithelium but EGF-R positivity disappears as the cells approach the luminal surface (A, original magnification X400). In the stomach, EGF-R positivity was seen on the basolateral surfaces on surface, parietal, and mucus neck cells with particularly strong staining on the parietal cells (B, original magnification X400). In the small intestine, EGF-R positivity was restricted to the basolateral membranes of the proliferative (crypt) region and the goblet cells of the villi, with little or no positivity on the villus enterocytes (C, original magnification X250). In the colon, EGF-R positivity was seen on the basolateral surfaces of cells in all regions of the crypts with relatively weak staining of the basolateral membranes of the surface colonocytes. (D, original magnification X400.) 20 followed by one wash in TBS (each wash for five minutes). The presence of the EGF-R proteins was then visualised using the ECL (chemiluminescence) system (Amersham, UK) by incubating in the ECL reagents for one minute as recommended by the manufacturer.
All assays were performed in quadruplicate.
To determine the specificity of the reaction, western blots were performed in which the primary antibody had been pre-incubated in excess recombinant EGF-R (kindly donated by W Gullick, ICRF).
Results
Immunohistochemistry and electron microscopy In the oesophagus, weak membrane localised EGF-R positivity was seen circumferentially in the deeper portions of the stratified squamous epithelium but surface cells were negative ( Fig  1A) . The gastric body and antrum epithelium showed EGF-R-like immunoreactivity in the basolateral membranes with particularly strong staining of the parietal cells. Surface membranes were consistently negative (Fig 1B) .
Duodenal and ileal tissue showed EGF-R-like positivity on the basolateral surfaces of the crypt regions (Fig 1 C) and on the goblet cells of the villi, however, the enterocytes on the villi appeared to be EGF-R negative. Colonic mucosa showed EGF-R-like positivity in a basolateral distribution in all regions of the crypts (Fig 1D) . Distribution of EGF-R positivity visualised using electron microscopy gave similar results (Fig 2) . Therefore, the apical/surface membranes abutting the intestinal lumen were consistently negative throughout the gastrointestinal tract. The negative control and slides in which excess recombinant EGF-R had been added showed no staining, confirming the specificity of the reaction.
Western blotting On each occasion, brush border preparations showed a pronounced increase in alkaline phosphatase activity (typical specific activity of alkaline phosphatase in ileal whole tissue homogenate was 0O1 U/mg protein compared with 0.9 U/mg protein in brush border preparations). The major band seen in duodenal and ileal whole tissue homogenates had an apparent molecular weight of approximately 170 kDa, with some fainter smaller bands (with apparent molecular weights of approximately 150 and 100 kDa) being inconsistently seen in whole tissue homogenates of ileal preparations. Brush border vesicle preparations from these tissues were consistently negative (Fig 3) . Importantly, no bands were seen in any of the lanes in parallel western blots in which the primary antibody had been preincubated in excess recombinant EGF-R.
Discussion
Using a variety of different techniques, we have examined the distribution of the EGF-R in the human gastrointestinal tract. All results Distribution of the EGF-R in normal gut _ : : < S . -> . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O . . . . . . . . . . . . . . . . . . i suggest that, in the normal human adult gut, the apical/surface membranes abutting the intestinal lumen do not express EGF-R.
We used two different antibodies (one monoclonal and one polyclonal) to examine the distribution of the EGF-R by immunohistochemistry to decrease the possibility of false EGF-R-like positivity. For all regions of the gastrointestinal tract, results were consistent between the two. The major form of EGF-R found in tissue homogenates of duodenum and ileum had an apparent molecular weight of about 170 kDa, although fainter bands were sometimes seen at approximately 150 and 100 kDa, probably representing partial degradation products of the EGF-R.
EGF is a 53 amino acid peptide (molecular weight 6400), which is secreted into the gastrointestinal lumen from the salivary glands and Brunner's glands of the duodenum.' Gastric Most ofthe previous studies in this area have examined the distribution of the EGF-R in animal models, particularly the rat. A paper by Thompson and coworkers suggests that, in the adult rat, the EGF-R is restricted to the basolateral membranes.10 However, species differences may exist as Kelly and coworkers reported that EGF-Rs are present on the apical membranes of the pig intestine (using the technique of autoradiographic localisation'1l).
There have been few equivalent studies performed in humans and these have mainly focused on the distribution of the EGF-R in the oesophagus and stomach. Using immunohistochemical staining, Jankowski and coworkers reported EGF-R-like positivity in a circumferential distribution in the basal portion of the stratified squamous epithelium of the oesophagus,'2 in keeping with our results. However, in contrast with our findings, they found that the EGF-R was present on the apical and basolateral membranes of the normal human stomach.'3 A similar apical distribution has been also reported in the adult stomach and colon by Hormi and Lehy.14 Reasons for these differences are unclear, although the methods used by both groups were restricted to immunohistochemical localisation and the antibodies used by each group (Ab-1 by Jankowski, and Ab-4 by Hormi and Lehy, both monoclonal IgG's obtained from Oncogene Science, Manhaset, NY, USA) were different from the two used in this study. A different monoclonal antibody (528IgG) was used by Mori and coworkers to examine the 
